Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism.

Source:http://linkedlifedata.com/resource/pubmed/id/20028383

Download in:

View as

General Info

PMID
20028383